NVS NOVELSTAR PHARMACEUTICALS INC. Trademark

Trademark Overview


On Wednesday, June 27, 2018, a trademark application was filed for NVS NOVELSTAR PHARMACEUTICALS INC. with the United States Patent and Trademark Office. The USPTO has given the NVS NOVELSTAR PHARMACEUTICALS INC. trademark a serial number of 88977137. The federal status of this trademark filing is REGISTERED as of Tuesday, May 5, 2020. This trademark is owned by Novelstar Pharmaceuticals Inc.. The NVS NOVELSTAR PHARMACEUTICALS INC. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services and pharmaceutical product evaluation services; providing services to others relating to analytical, chemistry and manufacturing controls for regulatory approval of small and large molecules drug products, namely, providing scientific information relating to the analysis and management of the drug manufacturing process for regulatory approval of small and large molecules drug products
nvs novelstar pharmaceuticals inc.

General Information


Serial Number88977137
Word MarkNVS NOVELSTAR PHARMACEUTICALS INC.
Filing DateWednesday, June 27, 2018
Status700 - REGISTERED
Status DateTuesday, May 5, 2020
Registration Number6049799
Registration DateTuesday, May 5, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 18, 2019

Trademark Statements


Description of MarkThe mark consists of a circle with enclosed stylized text of "NVS", followed by text which reads "Novelstar", under which is set forth a text "Pharmaceuticals Inc.".
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMACEUTICALS INC."
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services and pharmaceutical product evaluation services; providing services to others relating to analytical, chemistry and manufacturing controls for regulatory approval of small and large molecules drug products, namely, providing scientific information relating to the analysis and management of the drug manufacturing process for regulatory approval of small and large molecules drug products

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, July 1, 2018
Primary Code042
First Use Anywhere DateMonday, December 31, 2018
First Use In Commerce DateSaturday, August 31, 2019

Trademark Owner History


Party NameNovelstar Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameNovelstar Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameNovelstar Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events


Event DateEvent Description
Saturday, June 30, 2018NEW APPLICATION ENTERED
Sunday, July 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 3, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 18, 2018ASSIGNED TO EXAMINER
Tuesday, October 23, 2018NON-FINAL ACTION WRITTEN
Tuesday, October 23, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 23, 2018NON-FINAL ACTION E-MAILED
Monday, March 11, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 11, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 1, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 1, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, April 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, April 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 16, 2019ASSIGNED TO LIE
Thursday, May 16, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 29, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2019PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, February 13, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, February 13, 2020TEAS REQUEST TO DIVIDE RECEIVED
Thursday, February 13, 2020DIVISIONAL REQUEST RECEIVED
Thursday, February 13, 2020USE AMENDMENT FILED
Tuesday, March 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 17, 2020DIVISIONAL PROCESSING COMPLETE
Tuesday, March 17, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, March 27, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, March 28, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 5, 2020REGISTERED-PRINCIPAL REGISTER
Monday, May 5, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, March 18, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED